Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Radiation Biology Irradiator Dose Verification Survey.

Pedersen KH, Kunugi KA, Hammer CG, Culberson WS, DeWerd LA.

Radiat Res. 2016 Feb;185(2):163-8. doi: 10.1667/RR14155.1. Epub 2016 Jan 15.

PMID:
26771174
2.

A prototype, glassless densitometer traceable to primary optical standards for quantitative radiochromic film dosimetry.

Rosen BS, Soares CG, Hammer CG, Kunugi KA, DeWerd LA.

Med Phys. 2015 Jul;42(7):4055-68. doi: 10.1118/1.4922134.

PMID:
26133606
3.

Determination of exit skin dose for 192Ir intracavitary accelerated partial breast irradiation with thermoluminescent dosimeters.

Raffi JA, Davis SD, Hammer CG, Micka JA, Kunugi KA, Musgrove JE, Winston JW Jr, Ricci-Ott TJ, DeWerd LA.

Med Phys. 2010 Jun;37(6):2693-702.

4.

Continuous 28-day iododeoxyuridine infusion and hyperfractionated accelerated radiotherapy for malignant glioma: a phase I clinical study.

Schulz CA, Mehta MP, Badie B, McGinn CJ, Robins HI, Hayes L, Chappell R, Volkman J, Binger K, Arzoomanian R, Simon K, Alberti D, Feierabend C, Tutsch KD, Kunugi KA, Wilding G, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1107-15.

PMID:
15234045
5.

Overexpression of the R2 subunit of ribonucleotide reductase in human nasopharyngeal cancer cells reduces radiosensitivity.

Kuo ML, Hwang HS, Sosnay PR, Kunugi KA, Kinsella TJ.

Cancer J. 2003 Jul-Aug;9(4):277-85.

PMID:
12967138
7.

Preclinical evaluation of 5-iodo-2-pyrimidinone-2'-deoxyribose as a prodrug for 5-iodo-2'-deoxyuridine-mediated radiosensitization in mouse and human tissues.

Kinsella TJ, Kunugi KA, Vielhuber KA, Potter DM, Fitzsimmons ME, Collins JM.

Clin Cancer Res. 1998 Jan;4(1):99-109.

8.

Defective expression of the DNA mismatch repair protein, MLH1, alters G2-M cell cycle checkpoint arrest following ionizing radiation.

Davis TW, Wilson-Van Patten C, Meyers M, Kunugi KA, Cuthill S, Reznikoff C, Garces C, Boland CR, Kinsella TJ, Fishel R, Boothman DA.

Cancer Res. 1998 Feb 15;58(4):767-78.

9.

The interaction of hydroxyurea and ionizing radiation in human cervical carcinoma cells.

Kuo ML, Kunugi KA, Lindstrom MJ, Kinsella TJ.

Cancer J Sci Am. 1997 May-Jun;3(3):163-73.

PMID:
9161782
10.

Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.

McGinn CJ, Kunugi KA, Tutsch KD, Feierabend C, Alberti D, Lindstrom MJ, Wilding G, Arzoomanian RZ, Kinsella TJ.

Clin Cancer Res. 1996 Aug;2(8):1299-305.

12.

The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.

Kuo ML, Kunugi KA, Lindstrom MJ, Kinsella TJ.

Cancer Res. 1995 Jul 1;55(13):2800-5.

13.
14.

The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.

McGinn CJ, Miller EM, Lindstrom MJ, Kunugi KA, Johnston PG, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 1994 Nov 15;30(4):851-9.

PMID:
7960987
15.
17.

Global comparison of radiation and chemotherapy dose-response curves with a test for interaction.

Lindstrom MJ, Kunugi KA, Kinsella TJ.

Radiat Res. 1993 Aug;135(2):269-77.

PMID:
7690150
18.
20.

Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.

Kunugi KA, Vazquez-Padua MA, Miller EM, Kinsella TJ.

Cancer Res. 1990 Aug 15;50(16):4962-7.

21.

Inhibition by ethambutol of mycolic acid transfer into the cell wall of Mycobacterium smegmatis.

Takayama K, Armstrong EL, Kunugi KA, Kilburn JO.

Antimicrob Agents Chemother. 1979 Aug;16(2):240-2.

22.

Effect of low temperature on growth, viability, and synthesis of mycolic acids of Mycobacterium tuberculosis strain H37Ra.

Takayama K, Armstrong EL, Davidson LA, Kunugi KA, Kilburn JO.

Am Rev Respir Dis. 1978 Jul;118(1):113-7.

PMID:
98081

Supplemental Content

Loading ...
Support Center